敏实集团（00425）：拟成立美国机器人合资公司

Investment Rating - The report maintains a "Buy" rating for the company [6][5]. Core Views - The company is establishing a joint venture in the U.S. with Harmonic Drive to develop humanoid robot joint modules, marking a significant step in its global robotics business expansion [1][2]. - The traditional business is expected to maintain steady growth, with the battery box business accelerating globally, and new strategic initiatives in robotics, AI, liquid cooling, and low-altitude economy potentially enhancing long-term growth prospects [1][3]. - The battery box business is entering a harvest phase, with revenue of 3.582 billion RMB in the first half of 2025, reflecting a year-on-year increase of 49.8% and a gross margin of 23.0% [4]. Summary by Sections Joint Venture and Global Expansion - On February 9, 2026, the company signed a framework agreement with Harmonic Drive to establish a joint venture in the U.S., with a 60% stake for the company and a 40% stake for Harmonic Drive, involving an investment of 10 million USD [2]. - The company has previously signed a strategic cooperation agreement with a leading robotics company for the European market, focusing on the production and distribution of general embodied intelligent robots [2]. New Business Developments - The company is diversifying into liquid cooling and low-altitude economy sectors, with significant orders from a global semiconductor company for liquid cooling cabinets and systems [3]. - A strategic partnership with EHang for eVTOL aircraft and rotor systems has been established, with intentions for mass production orders [3]. - The company has issued 2.4 million shares as part of a zero-cost equity incentive plan, targeting core R&D personnel in new strategic areas [3]. Financial Performance and Projections - The company expects revenues of 27.774 billion RMB in 2025, 32.033 billion RMB in 2026, and 36.851 billion RMB in 2027, with net profits projected at 2.847 billion RMB, 3.430 billion RMB, and 4.070 billion RMB respectively [9][5]. - The target price is set at 49.71 HKD for 2026, corresponding to a PE ratio of 15.2 times, and a target price of 127.13 USD for the U.S. market [5][6].